Summary
The efficacy and tolerability of Timegadine, a new antirheumatic agent, administered at a dose of 250 mg twice daily was evaluated in an open trial of 24 weeks' duration in 31 patients with active rheumatoid arthritis. The subjective and objective clinical parameters improved significantly from the 2nd to 6th week of treatment. For some of the parameters further improvement was observed during the continuation of the treatment. At 6 weeks the ESR was significantly decreased, and a further reduction of the ESR was seen with the continuation of the treatment. At the end of the treatment period other humoral parameters of the disease were significantly modified. Moreover, in 65% of the patients with seropositive rheumatoid arthritis a reduction of the rheumatoid factor titre by at least two dilutions was observed. Five of the 31 patients were withdrawn from treatment due to the appearance of side effects. Although the study was open and the number of patients relatively small, the observed changes in the laboratory parameters of disease activity encourage further investigations to assess the potential of Timegadine as a remissive drug.
Similar content being viewed by others
References
Rachlin, S., Bramm, E., Ahnfelt-Rønne, I., Arrigoni-Martelli, E. Basic anti-inflammatory compounds N,N′N-trisubstituted guanidines. J. Med. Chem. 1980, 23, 13–20.
Bramm, E., Binderup, L., Arrigoni-Martelli, E. An unusual profile of activity of a new basic antiinflammatory drug, Timegadine. Agents Actions 1981, 11, 402–409.
Ahnfelt-Rønne, I., Arrigoni-Martinelli, E. A new anti-inflammatory compound, Timegadine (N-cyclohexyl-N″4-(2-methylquinolyl)-N′-2-thiazolylguani dine) which inhibits both prostaglandin and 12 hydroxyeicosetetraenoic acid (12-HETE) formation. Biochem. Pharmacol. 1980, 29, 3265–3269.
Ahnfelt-Rønne, I., Arrigoni-Martelli, E. Multiple effects of a new anti-inflammatory agent, Timegadine on arachidonic acid release and metabolism in neutrophils and platelets. Biochem. Pharmacol. 1982, in press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caruso, I., Fumagalli, M., Montrone, F. et al. Timegadine: long-term open study in rheumatoid arthritis. Clin Rheumatol 2, 363–367 (1983). https://doi.org/10.1007/BF02041556
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02041556